课题基金 / 基金详情

项目摘要

项目成果

KARL D. KIEBURTZ的其他基金

相似基金

相关文献

中文摘要
翻译
罗彻斯特临床和转化科学奖(RCTSA)计划提出继续其双重目标:1)组织,支持和扩大罗彻斯特大学的临床和转化研究,在一个学术家,罗彻斯特大学临床和转化科学研究所(URCTSI)内,2)整合和合作,与地区和国家机构扩大一个国家研究中心
英文摘要
The Rochester Clinical and Translational Science Award (RCTSA) Program proposes continuation of its dual goals: 1) To organize, support, and expand clinical and translational research at the University of Rochester within an academic home, the University of Rochester Clinical and Translational Science Institute (URCTSI), and 2) To integrate and collaborate with regional and national institutions to expand a National Clinical and Translational Research Network. The RCTSA Program has truly transformed the University of Rochester Medical Center (URMC), with the construction of a state-of-the-art Clinical and Translational Science Building, the integration of clinical and translational science into the shared vision for URMC research, a successful system of dynamic governance, expansion of research resources, and enthusiastic participation and leadership in the National CTSA Consortium. To continue this momentum, the UR-CTSI will carry out a number of specific aims. First, three new key functions will be implemented: Public-Private Partnerships, Tl Translation, and Comparative Effectiveness Research. Existing Key Functions will be reorganized and consolidated to provide better support of investigators by an expanded Office of Regulatory Support, a Navigator/Consultation Service, and an Incubator Program consolidating Pilot Studies, Novel Methodologies, and Translational Technologies Key Functions. The CTSI will establish and foster four centers of research excellence across the spectrum of research translation: Center for Human Experimental Therapeutics (Tl Research); Clinical Research Center (T1-3 Research); Center for Research Implementation and Translation (T2-3 research under School of Nursing sponsorship); and Center for Community Health (T2-3 research). A broad range of education, training, and career development programs will continue to meet research workforce needs. The UR-CTSI will be an active participant in the National CTSA consortium with sharing of expertise, methods, data, and curricula. The Upstate New York Translational Research Network (UNYTRN) will be expanded to support the region's biomedical research institutions. Finally, the UR-CTSI will be evaluated through the measurement of rigorous performance outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
  • 批准号:
    10017340
  • 项目类别:
  • 资助金额:
    $17.21万
  • 财政年份:
    2018
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
  • 批准号:
    10459490
  • 项目类别:
  • 资助金额:
    $17.73万
  • 财政年份:
    2018
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
Research Project 1 will develop in silico models that predict PD progression and inform clinical trial design
  • 批准号:
    10242056
  • 项目类别:
  • 资助金额:
    $17.73万
  • 财政年份:
    2018
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
U.S. India Collaborative Partnership in Parkinson Disease (CPPD)
  • 批准号:
    8337850
  • 项目类别:
  • 资助金额:
    $18.64万
  • 财政年份:
    2011
  • 负责人:
    KARL D. KIEBURTZ
  • 依托单位:
海外基金